5. Zelefsky MJ, Yamada Y, Cohen G, Venkatraman ES, Fung AY, Furhang E, Sivern D,
Zaider M. Post implantation dosimetric analysis of permanent transperineal prostate …

In telephone interviews after the meeting, Drs. Higano and Eisenberger said they did then
talk briefly to each other outside the room about the differences between the two trials. But it …

Oncologists take great pride in basing practice on the evidence that comes from well-
designed trials. Critical appraisal of clinical data requires a firm grounding in the precepts of …

Abstract At the 2014 Genitourinary Cancers Symposium (GU-ASCO 2014), international
researchers presented an extensive array of research in the field of prostate cancer …

The treatment we should offer an individual patient must be the one we believe has the
greatest chance of providing benefit, balanced against unwanted acute and late effects, and …

“Is my disease curable?” That's the first question patients usually ask after learning they
have prostate cancer, says Patrick Walsh, a surgeon and urology professor at Johns …

Massive amounts of new literature are published each year, providing varied levels of
evidence to the medical urology community. Despite the peer-review processes in place …

OBJECTIVE: To present guidelines for the analysis and presentation of clinical trials on
prostate cancer. METHODS: Textbooks in statistics and oncology were searched for …

The field of prostate cancer is important, changing, and confusing. Prostate cancer is the
most frequent cancer and the second most common cause of cancer death among US men …

To the Editor: I read with interest the preliminary analysis reported by Wallner et al. entitled
“125I versus 103Pd for low-risk prostate cancer: Preliminary PSA outcomes from a …